Rallybio Corp
For the period ended Dec 31, 2025. Filed Mar 16, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 16, 2026
RLYB$15.66-0.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| (in thousands, except share and per share amounts) | DECEMBER 31,2025 | DECEMBER 31,2024 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $31,374 | $13,903 |
| Marketable securities | 23,362 | 51,608 |
| Prepaid expenses and other current assets | 6,517 | 2,330 |
| Total current assets | 61,253 | 67,841 |
| Property and equipment, net | 23 | 115 |
| Operating lease right-of-use assets | 175 | 152 |
| Other assets, noncurrent | 810 | — |
| Total assets | $62,261 | $68,108 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $126 | $278 |
| Accrued expenses | 3,791 | 4,962 |
| Operating lease liabilities | 94 | 154 |
| Deferred revenue | 212 | 848 |
| Total current liabilities | 4,223 | 6,242 |
| Operating lease liabilities, noncurrent | 82 | — |
| Deferred revenue, noncurrent | — | 212 |
| Total liabilities | 4,305 | 6,454 |
| Commitments and contingencies (Note 10) | ||
| Stockholders' equity | ||
| Common stock, $0.0001 par value per share; 200,000,000 shares authorized as of December 31, 2025 and 2024; and 5,283,321 and 5,188,743 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 4 | 4 |
| Preferred stock, $0.0001 par value per share; 50,000,000 shares authorized as of December 31, 2025 and 2024; no shares issued or outstanding as of December 31, 2025 and 2024 | — | — |
| Additional paid-in capital | 359,932 | 354,602 |
| Accumulated other comprehensive gain | 18 | 68 |
| Accumulated deficit | (301,998) | (293,020) |
| Total stockholders' equity | 57,956 | 61,654 |
| Total liabilities and stockholders' equity | $62,261 | $68,108 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.